Winner's curse

Winner's curseWhile the price of Guidant has risen, so have the estimates of the number of its devices that are defective. Over the next few years we'll see if Boston Scientific paid too much.

Previous
Previous

Singing the blues on health care coverage

Next
Next

Do mutual fund managers have more fun?